Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
96 Cards in this Set
- Front
- Back
AAA Screening |
MEN 65-75 who have EVER smoked. - Level B |
|
Screening for abnormal blood glucose/DM2 |
Anyone 40-70 years who is overweight or obese without other risk factors. Send to intensive behavioral counseling. - Level B (Consider earlier screening if +family history, gestational diabetes, PCOS, or high risk ethnic groups) |
|
Alcohol screening and counseling |
18 and older (insufficient evidence for teenagers). Brief behavioral counseling for intervention. - Level B (Note this guideline is currently being updated) |
|
Aspirin for prevention of CVD and colorectal cancer |
Age 50-59 with 10% or greater 10 year CVD risk score, no bleeding risk, 10 year life expectancy, and willing to take it for at least 10 years - Level B (Age 60-69 is level C. Anything <50 or >70 level I) |
|
Screening for asymptomatic bacteriuria |
Pregnant women 12-16 weeks gestation ONLY. - Level A |
|
Autism screening 18-30 months |
No (Insufficient evidence to screen unless concerns are raised by parents or clinician) |
|
Bacterial vaginosis screening in pregnancy |
Do NOT screen asymptomatic women. (Even those at HIGH RISK for preterm delivery has insufficient evidence). |
|
Bladder Cancer screening in adults |
NO (Insufficient evidence to screen asymptomatic adults) |
|
HTN screening in children and adolescents |
No (Insufficient evidence to screen asymptomatic pediatric patients. No evidence that screening reduces adverse cardiovascular outcomes in adulthood) |
|
BRCA assessment, counseling, and testing |
Several steps: 1) +Family history of breast, ovarian, tubal, or peritoneal cancer 2) Then use a screening tool 3) If positive refer to genetic counseling 4) If indicated after counseling THEN test for the gene. - Level B |
|
Breast Cancer medications for risk reduction |
SHARED decision making. If high risk for cancer (but NO prior personal history of breast cancer) and low risk for adverse effects (No thromboembolic history) offer Tamoxifene (Age 35+) or Raloxifene (postmenopausal). - Level B |
|
Breast Cancer screening |
Biennial screening mammography 50-74 years of age. - Level B (Ages 40-49 only if the woman wants it and values the benefits over the harms). |
|
Breastfeeding interventions by primary care |
YES! Provide interventions and support both during pregnancy and after birth. - Level B |
|
Carotid artery stenosis screening |
No! (If asymptomatic then evidence is Level D in the general adult population) |
|
Cervical Cancer screening |
Pap smear every 3 years ages 21-65. OR Every 5 years ages 30-65 if done WITH HPV testing. - Level A (Does not apply to women with prior cancer or high grade precancerous lesion, HIV, immunocompromised, DES exposure in utero) |
|
Child maltreatment interventions by PCP |
If no signs of abuse or maltreatment then insufficient evidence to perform any type of intervention (Note that maltreatment, abuse, and neglect have different definitions) |
|
Chlamydia and Gonorrhea screening |
24 years and younger if at all sexually active. Older women if high risk. - Level B (Insufficient evidence to screen men) |
|
CKD screening |
No Not in asymptomatic adults. Insufficient evidence to screen. (This does NOT include adults with HTN, DM, etc.) |
|
COPD screening |
No! (Do NOT screen asymptomatic adults - Level D) |
|
Cognitive impairment screening in older adults |
No Insufficient evidence |
|
Colorectal cancer screening |
Screen ages 50-75 using one of the approved methods and intervals. - Level A (Ages 76-85 depend on risks and benefits, life expectancy, etc. Level C) |
|
Congenital hypothyroidism screening |
Defer to DACHDNC guidelines? |
|
CHD screening (using non traditional risk factors) |
Insufficient evidence to screen with non-traditional tools such as ABI, CRP, Calcification score, etc if patient is asymptomatic? (Confusing guideline. Please correct me if I read this one wrong) |
|
CHD screening with ECG |
No! (Do NOT screen asymptomatic adults at low risk with an ECG in order to evaluate CHD. - Level D) |
|
Dental and Periodontal Disease counseling |
Old recommendations are now INACTIVE. No USPSTF recommendations on this subject |
|
Screening for Dental Caries in children age 5 or less |
Provide oral fluoride supplementation starting at 6 months if none in water supply PCP should apply fluoride varnish once 1st tooth erupts - Level B |
|
Depression in adults screening |
Yes. Screen pregnant, postpartum, and general adult population. Make sure you have systems in place to appropriately treat them and follow up. - Level B |
|
Depression in children and adolescents screening |
Screen ages 12-18 for MDD with adequate systems in place to diagnose, treat, and follow up. - Level B |
|
Developmental hip dysplasia screening |
No. Insufficient evidence to screen asymptomatic babies. |
|
Illicit drug use interventions for children and adolescents |
No Insufficient evidence for any PCP behavioral intervention if they are not already diagnosed with a substance disorder. |
|
Illicit drug use screening |
No Insufficient evidence to screen asymptomatic adults, adolescents, pregnant women |
|
Fall prevention in older adults |
Offer exercise or PT and Vit D supplementation to adults 65 years or older at increased risk of falls. (There is no good screening tool for this recommended). - Level B (Do not just automatically do a comprehensive screening and assessment in older adults. Let the past history or comorbidities lead you. Level C) |
|
Folic Acid for prevention of neural tube defects |
YES! ALL women capable of childbearing should take 0.4 to 0.8 mg folic acid daily. - Level A |
|
Genital Herpes screening |
No! Do NOT routinely screen in asymptomatic adolescents, adults, or pregnant women. Level D |
|
Gestational Diabetes screening |
Screen asymptomatic women after 24 weeks gestation. - Level B |
|
Glaucoma screening |
No Insufficient evidence to screen asymptomatic adults for open angle glaucoma |
|
Gynecologic cancers counseling |
Now inactive. No guidelines from USPSTF |
|
Diet and physical activity counseling in adults with CVD risk factors |
Offer or refer all overweight or obese adults with other CVD risk factors to intensive behavioral counseling. |
|
Diet and physical activity counseling in adults not at high risk |
Behavioral counseling on diet and exercise has little benefit in this population. - Level C |
|
Hearing loss screening in newborns |
Inactive. No guidelines from USPSTF |
|
Hearing loss in older adults screening |
No Insufficient evidence to screen asymptomatic adults older than age 50 |
|
Hemochromatosis screening |
Inactive. No USPSTF guidelines |
|
Hep B screening in pregnant women |
Yes! Screen at first prenatal visit |
|
Hep B screening |
Screen people at high risk for infection (hemodialysis, immunocompromised, not vaccinated, etc). - Level B |
|
Hep C screening |
Screen those at high risk (incarceration, tattoos, IV drug use, blood transfusion before 1992, etc) and one time for anyone born between 1945-1965. - Level B |
|
HTN in adults screening |
Screen adults 18 and over. Get readings outside the clinic setting for confirmation before starting treatment if possible. - Level A |
|
HIV screening |
Yes! Screen ages 15-65, pregnant women, and anyone else at high risk. - Level A (Note that screening intervals can vary according to risk. No set recommendation. 1 year if high risk, 3-5 if low risk is decent). |
|
Hyperbilirubinemia screening in infants |
Inactive. No USPSTF recommendations |
|
Screening for idiopathic scoliosis in adolescents |
No! Do NOT screen asymptomatic adolescents. Level D |
|
Immunizations for adults |
Defer to CDC guidelines |
|
Immunizations for children |
Defer to CDC guidelines |
|
Impaired visual acuity screening in older adults |
No. Insufficient evidence in asymptomatic adults |
|
Screening for intimate partner violence and abuse of the elderly/vulnerable |
Screen women of childbearing age and provide or refer for intervention. - Level B (Insufficient evidence to screen asymptomatic elderly or vulnerable adults). |
|
Screening and supplementation for iron deficiency anemia in pregnancy |
No Insufficient evidence to routinely screen or supplement iron during pregnancy |
|
Iron deficiency anemia screening in young children |
Insufficient evidence in 6-24 months |
|
Latent TB infection screening |
Screen in at risk populations (immunocompromised, prisons, homeless, some foreign countries, etc). - Level B (Note that USPSTF does not make recommendations on screening medical providers) |
|
Lead level screening in childhood and pregnancy |
No! Do not screen asymptomatic children ages 1-5 or pregnant women. - Level D (Even children at high risk have insufficient evidence for screening if asymptomatic). |
|
Lipid disorder screening in children and adolescents |
No Insufficient evidence to screen anyone 20 years of age or younger |
|
Low dose aspirin to prevent morbidity and mortality in preeclampsia |
Yes, give 81mg aspirin daily after 12 weeks gestation in women at high risk (previous preeclampsia, multigestation, HTN, DM 1 or 2, renal disease, autoimmune disease) for preeclampsia. - Level B |
|
Lung cancer screening |
Annual low dose CT screening in people 55-80 with 30 pack year history who are currently smoking or quit in the past 15 years. (Unless unable to even have lung surgery due to poor health or unwillingness). - Level B |
|
Menopausal horomone preventative therapy |
No! Do NOT use estrogen or combination medicine for prevention of chronic disease in asymptomatic postmenopausal women. Level D (Does not apply to women <50 with menopause 2/2 surgery) |
|
Motor vehicle restraints counseling |
Refer to CDC community guide |
|
Obesity in adults - screening and management |
Screen all adults for obesity. BMI 30 or higher need intensive multicomponent behavioral interventions. - Level B |
|
Obesity screening in children and adolescents |
Screen children age 6 and older and offer or refer to comprehensive, intensive behavioral intervention. |
|
OSA screening in adults |
No Insufficient evidence to screen asymptomatic adults for OSA. |
|
Neonatal ocular gonorrhea prevention |
Yes! Prophylactic topical ocular treatment ALL newborns. - Level A |
|
Oral cancer screening |
No Insufficient evidence to screen asymptomatic adults. |
|
Osteoporosis screening |
Yes, screen women 65 years and older as well as women whose fracture risk is equal to or greater than an otherwise healthy 65 year old woman (that is to say a 9.3% 10 year risk). - Level B (insufficient evidence to screen men) |
|
Ovarian cancer screening |
No! Do NOT screen asymptomatic women for ovarian cancer. - Level D |
|
Pancreatic cancer screening |
No! Do NOT screen asymptomatic adults (this includes abdominal palpation, US, or serologic markers). - Level D |
|
CVD and PAD risk assessment in adults with ABI |
No Insufficient evidence to screen for these via ABI |
|
Phenylketonuria screening in newborns |
Refer to DACHDNC guidelines |
|
Preeclampsia screening |
No recommendations |
|
Prostate cancer screening |
No! Do NOT screen with a PSA. - Level D |
|
RhD incompatability screening |
Blood typing and antibody testing during first prenatal visit. - Level A Repeat antibody testing at 24-28 weeks gestation for all unsensitized RhD negative women unless father is KNOWN to be RhD negative. - Level B |
|
Rubella immunization |
Refer to CDC guidelines |
|
Rubella screening |
Inactive. No USPSTF guideline |
|
STI behavioral counseling |
Yes, intensive behavioral counseling for all sexually active adolescents and adults at increased risk for STIs. - Level B |
|
Sickle Cell Disease screening in newborns |
Refer to DACHDNC |
|
Skin cancer counseling |
Counsel everyone 10-24 years of age with fair skin about minimizing UV radiation. - Level B (Insufficient evidence >24 years of age) |
|
Skin cancer screening |
Insufficient evidence for visual skin exam by a clinician |
|
Speech and language delay screening in children age 5 and younger |
Insufficient evidence to screen this population |
|
Statin use for prevention of CVD |
Give a low-moderate dose statin to adults 40-75 with no history of CVD, 1 or more risk factors, and 10 year risk score of 10% or greater. Level B (risk score of 7.5-10% is Level C evidence. Insufficient evidence for people > 75 years of age) |
|
Suicide risk screening |
No Insufficient evidence to screen asymptomatic adolescents, adults, or elderly in a primary care setting. |
|
Syphilis screening in the non pregnant population |
Yes, screen those at increased risk (HIV + and men who have sex with men especially). - Level A |
|
Syphilis screening in pregnancy |
Yes, screen all pregnant women. - Level A |
|
Testicular cancer screening |
No! Do NOT screen adolescent or adult men. Level D |
|
Thyroid cancer screening |
No Current recommendations (this is currently being updated) |
|
Thyroid dysfunction screening |
No Insufficient evidence to screen in asymptomatic, non pregnant adults. |
|
Tobacco smoking cessation in adults |
Ask ALL adults about smoking, advise on cessation, and provide behavioral counseling as well as FDA approved pharmocotherapy. In pregnant women do the same except for pharmacotherapy. - Level A (Insufficient evidence to give pregnant women pharmacotherapy or to recommend electronic nicotine systems to anyone) |
|
Tobacco use in children and adolescents intervention |
Yes, provide education, brief counseling, or other interventions to PREVENT initiation of tobacco in school aged children. - Level B |
|
Visual impairment screening in ages 3-5 |
Yes, screen at least once between ages 3-5 to detect amblyobia or its risk factors. - Level B (insufficient evidence < 3 years of age) |
|
Vit D and Calcium to prevent fractures |
As noted previously, give to adults >65 at increased risk for falls. - Level B For everyone else evidence rating is I or even D so don't do it for primary prevention. |
|
Vit D deficiency screening |
No Insufficient evidence to screen asymptomatic adults. |
|
Vitamin supplementation to prevent cancer and CVD |
No! Beta carotene and Vit E are Level D! Everything else has insufficient evidence |
|
Youth violence counseling |
Refer to CDC community guide |